Cumulative data from preclinical studies show the utility of BDNF and CNTF for conferring various neuroprotective effects led to the idea that these NTFs could be a clinically applicable therapeutic target in neurodegenerative diseases [16,18,43]. The gene discussed is BDNF; the disease is neurodegenerative disease.